dimaprit has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seifert, R | 1 |
| Höer, A | 1 |
| Schwaner, I | 1 |
| Buschauer, A | 1 |
1 other study available for dimaprit and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
Topics: Adenosine Triphosphate; Calcium; Cations; Cell Differentiation; Cyclic AMP; Cytosol; Dimaprit; Famot | 1992 |